EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations

Daniela Mokra iD, Igor Porvaznik, Juraj Mokry iD

International Journal of Molecular Sciences · 15.03.2025 · 26 (6) · 2657

DOI: 10.3390/ijms26062657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2025. Verfasst von Daniela Mokra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia. Hauptthemen laut MEDLINE: Acetylcysteine, Acute Lung Injury. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency, Ministry of Education, Science, Research and Sport of the Slovak Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-acetylcysteine (NAC) can take part in the treatment of chronic respiratory diseases because of the potent mucolytic, antioxidant, and anti-inflammatory effects of NAC. However, less is known about its use in the treatment of acute lung injury. Nowadays, an increasing number of studies indicates that early administration of NAC may reduce markers of oxidative stress and alleviate inflammation in animal models of acute lung injury (ALI) and in patients suffering from distinct forms of acute respiratory distress syndrome (ARDS) or pulmonary infections including community-acquired pneumonia or Coronavirus Disease (COVID)-19. Besides low costs, easy accessibility, low toxicity, and rare side effects, NAC can also be combined with other drugs. This article provides a review of knowledge on the mechanisms of inflammation and oxidative stress in various forms of ALI/ARDS and critically discusses experience with the use of NAC in these disorders. For preparing the review, articles published in the English language from the PubMed database were used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineAcute Lung InjuryHumansAnimalsOxidative StressRespiratory Distress SyndromeCOVID-19AntioxidantsCOVID-19 Drug TreatmentSARS-CoV-2Anti-Inflammatory Agents

Stichwörter der Autor:innen

ARDSCOVID-19N-acetylcysteineacute lung injury

Substanzen

AcetylcysteineAntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia.
  • Department of Laboratory Medicine, Faculty of Health Sciences, Catholic University in Ružomberok, SK-03401 Ružomberok, Slovakia.
  • Department of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia.

ORCID-Profile: Daniela Mokra, Juraj Mokry

Förderung

  • Slovak Research and Development Agency
  • Ministry of Education, Science, Research and Sport of the Slovak Republic

Zitieren

APA

Mokra, D., Porvaznik, I., & Mokry, J. (2025). N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations. International Journal of Molecular Sciences, 26(6), 2657. https://doi.org/10.3390/ijms26062657

Vancouver

Mokra D, Porvaznik I, Mokry J. N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations. International Journal of Molecular Sciences. 2025;26(6):2657. doi:10.3390/ijms26062657

BibTeX
@article{Mokra2025,
  author = {Mokra, Daniela and Porvaznik, Igor and Mokry, Juraj},
  title = {N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2657},
  doi = {10.3390/ijms26062657}
}
Kostenlos starten →